Yahoo Αναζήτηση Διαδυκτίου

Sign In

Αποτελέσματα Αναζήτησης

  1. www.accessdata.fda.gov › drugsatfda_docs › labelORTHO EVRA® (norelgestromin / ethinyl estradiol TRANSDERMAL...

    ORTHO EVRA ® is a combination transdermal contraceptive patch with a contact surface area of 20 cm. 2. It contains 6.00 mg norelgestromin (NGMN) and 0.75 mg ethinyl estradiol (EE). Systemic...

  2. cdn.mdedge.com › files › s3fs-publicORTHO EVRA (NORELGESTROMIN / ETHINYL ESTRADIOL TRANSDERMAL...

    ORTHO EVRA® is a combination transdermal contraceptive patch with a contact surface area of 20 cm 2 .It contains 6.00 mg norelgestromin and 0.75 mg ethinyl estradiol (EE),and releases 150 micrograms of norelgestromin and 20 micrograms of EE to the bloodstream per 24 hours.

  3. pdf.hres.ca › dpd_pm › 00065628PRODUCT MONOGRAPH - pdf.hres.ca

    The EVRA® (norelgestromin and ethinyl estradiol) transdermal system is indicated for the prevention of pregnancy. The pharmacokinetic profile for the EVRA® transdermal system is different from that of an oral contraceptive. The clinical relevance of the differences in PK profiles between

  4. www.ema.europa.eu › product-information › evra-epar-product-information_enANNEX I SUMMARY OF PRODUCT CHARACTERISTICS - European Medicines...

    1. NAME OF THE MEDICINAL PRODUCT. EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Each 20 cm2 transdermal patch contains 6 mg norelgestromin (NGMN) and 600 micrograms ethinyl estradiol (EE).

  5. pubchem.ncbi.nlm.nih.gov › compound › ORTHO-EVRAOrtho Evra | C21H29NO2 | CID 9568628 - PubChem

    Ortho Evra. PubChem CID. 9568628. Structure. Molecular Formula. C21H29NO2. Synonyms. Norelgestromin. 53016-31-2. anti-Norelgestromin. Norgestimate metabolite Norelgestromin. ( (E)-Norelgestromin) View More... Molecular Weight. 327.5 g/mol. Computed by PubChem 2.2 (PubChem release 2021.10.14) Dates. Create: 2006-10-23. Modify: 2024-10-12.

  6. www.ema.europa.eu › en › medicinesEvra - European Medicines Agency (EMA)

    Overview. This is a summary of the European public assessment report (EPAR) for Evra. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Evra.

  7. pubchem.ncbi.nlm.nih.gov › compound › 44151751Ortho-Evra | C41H53NO4 | CID 44151751 - PubChem

    Ortho-Evra | C41H53NO4 | CID 44151751 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.